Comparative validation of breast cancer risk prediction models and projections for future risk stratification

Parichoy Pal Choudhury, Amber N. Wilcox, Mark N. Brook, Yan Zhang, Thomas Ahearn, Nick Orr, Penny Coulson, Minouk J. Schoemaker, Michael E. Jones, Mitchell H. Gail, Anthony J. Swerdlow, Nilanjan Chatterjee, Montserrat Garcia-Closas

Research output: Contribution to journalArticlepeer-review


Background Well-validated risk models are critical for risk stratified breast cancer prevention. We used the Individualized Coherent Absolute Risk Estimation (iCARE) tool for comparative model validation of five-year risk of invasive breast cancer in a prospective cohort, and to make projections for population risk stratification. Methods Performance of two recently developed models, iCARE-BPC3 and iCARE-Lit, were compared with two established models (BCRAT, IBIS) based on classical risk factors in a UK-based cohort of 64,874 women (863 cases) aged 35-74 years. Risk projections in US White non-Hispanic women aged 50-70 years were made to assess potential improvements in risk stratification by adding mammographic breast density (MD) and polygenic risk score (PRS). Results The best calibrated models were iCARE-Lit (expected to observed number of cases (E/O)=0.98 (95% confidence interval [CI]=0.87 to 1.11)) for women younger than 50 years; and iCARE-BPC3 (E/O=1.00 (0.93 to 1.09)) for women 50 years or older. Risk projections using iCARE-BPC3 indicated classical risk factors can identify ~500,000 women at moderate to high risk (>3% five-year risk). Additional information on MD and a PRS based on 172 variants is expected to increase this to ~3.6 million, and among them, ~155,000 invasive breast cancer cases are expected within five years. Conclusions iCARE models based on classical risk factors perform similarly or better than BCRAT or IBIS. Addition of MD and PRS can lead to substantial improvements in risk stratification. Independent prospective validation of integrated models is needed prior to clinical evaluation risk stratified breast cancer screening and prevention.

Original languageEnglish (US)
JournalUnknown Journal
StatePublished - Oct 19 2018


  • breast cancer
  • prevention
  • risk prediction
  • risk stratification
  • screening
  • validity

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)
  • Immunology and Microbiology(all)
  • Neuroscience(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Fingerprint Dive into the research topics of 'Comparative validation of breast cancer risk prediction models and projections for future risk stratification'. Together they form a unique fingerprint.

Cite this